G-protein β3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 5, 2010, Pages 934-941

  Maree, A O ^a,b   Vangjeli, C ^a   Jneid, H ^c   Ryan, J ^d   Cox, D ^a   Cannon, C P ^e   Shields, D C ^f   Fitzgerald, D J ^f  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b WATERFORD REGIONAL HOSPITAL   (Ireland)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bleeding; Cardiovascular disease; Genetics; Pharmacology; Platelets; Thrombosis

Indexed keywords

G PROTEIN BETA POLYPEPTIDE 3; GUANINE NUCLEOTIDE BINDING PROTEIN; ORBOFIBAN; PLACEBO; UNCLASSIFIED DRUG; ALANINE; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PYRROLIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; FIBRINOLYTIC THERAPY; GENETIC POLYMORPHISM; GENETICS; HEART DISEASE;

ALANINE; HEART DISEASES; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PYRROLIDINES; THROMBOLYTIC THERAPY;

EID: 77953796058     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03775.x     Document Type: Article

References (30)

1. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986, 315:983-9.
2. Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007, 115:2196-207.
3. O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH, D'Agostino RA, Levy D, Tofler GH. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001, 103:3051-6.
4. Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Vaidya D, Moy TF, Fallin MD, Wilson AF, Bray PF, Becker LC, Becker DM. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation 2007, 115:2490-6.
5. Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, Moy TF, Becker LC, Faraday N. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006, 295:1420-7.
6. Shields DC, Fitzgerald AP, O'Neill PA, Muckian C, Kenny D, Moran B, Cannon CP, Byrne CE, Fitzgerald DJ. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists. Pharmacogenomics J 2002, 2:182-90.
7. O'Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 2001, 98:3256-60.
8. Maree AO, Curtin RJ, Chubb A, Dolan C, Cox D, O'Brien J, Crean P, Shields DC, Fitzgerald DJ. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005, 3:2340-5.
9. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998, 18:45-8.
10. Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano JE, Wilson AF, Becker LC, Becker DM. Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost 2007, 5:1617-23.
11. Naber CK, Baumgart D, Heusch G, Siffert W, Oldenburg O, Huesing J, Erbel R. Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of alpha-adrenergic coronary constriction. Pharmacogenetics 2003, 13:279-84.
12. Sperling H, Eisenhardt A, Virchow S, Hauck E, Lenk S, Porst H, Stief C, Wetterauer U, Rubben H, Muller N, Siffert W. Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: a pilot study. J Urol 2003, 169:1048-51.
13. Hauner H, Meier M, Jockel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003, 13:453-9.
14. Cannon CP, McCabe CH, Wilcox RG, Langer A, Caspi A, Berink P, Lopez-Sendon J, Toman J, Charlesworth A, Anders RJ, Alexander JC, Skene A, Braunwald E. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 2000, 102:149-56.
15. Frey UH, Aral N, Muller N, Siffert W. Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation. Thromb Res 2003, 109:279-86.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
17. von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schomig A, Kastrati A. G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease. Atherosclerosis 2003, 167:135-9.
18. Wascher TC, Paulweber B, Malaimare L, Stadlmayr A, Iglseder B, Schmoelzer I, Renner W. Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosis. Stroke 2003, 34:605-9.
19. Klintschar M, Stiller D, Schwaiger P, Kleiber M. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight. Forensic Sci Int 2005, 153:142-6.
20. Alexander KP, Chen AY, Newby LK, Schwartz JB, Redberg RF, Hochman JS, Roe MT, Gibler WB, Ohman EM, Peterson ED. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 2006, 114:1380-7.
21. Richardson M, Robishaw JD. The alpha2A-adrenergic receptor discriminates between Gi heterotrimers of different betagamma subunit composition in Sf9 insect cell membranes. J Biol Chem 1999, 274:13525-33.
22. Sun A, Ge J, Siffert W, Frey UH. Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur J Hum Genet 2005, 13:361-9.
23. Maree A, Curtin R, Dooley M, O'Brien J, Crean P, Cox D, Fitzgerald D. Genetic determinants of epinephrine-induced platelet aggregation and aspirin resistance. Eur Heart J 2004, 25:221-444.
24. Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature 1999, 401:808-11.
25. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998, 339:436-43.
26. Simoons ML. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001, 357:1915-24.
27. Dobrev D, Wettwer E, Himmel HM, Kortner A, Kuhlisch E, Schuler S, Siffert W, Ravens U. G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. Circulation 2000, 102:692-7.
28. von Beckerath N, Kastrati A, Koch W, Bottiger C, Mehilli J, Seyfarth M, Schomig A. G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis 2000, 149:151-5.
29. Schreieck J, Dostal S, von Beckerath N, Wacker A, Flory M, Weyerbrock S, Koch W, Schomig A, Schmitt C. C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J 2004, 148:545-50.
30. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du PHA, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999, 10:1921-30.